Heron Therapeutics Inc (HRTX) Stock: What Does the Chart Say Tuesday?

Overall market sentiment has been down on Heron Therapeutics Inc (HRTX) stock lately. HRTX receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Heron Therapeutics Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on HRTX!

See Full HRTX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With HRTX Stock Today?

Heron Therapeutics Inc (HRTX) stock is lower by -2.71% while the S&P 500 is up 0.3% as of 11:42 AM on Tuesday, Mar 26. HRTX has fallen -$0.08 from the previous closing price of $2.95 on volume of 506,228 shares. Over the past year the S&P 500 is up 31.58% while HRTX is up 65.90%. HRTX lost -$0.80 per share in the over the last 12 months. To see InvestorsObserver's Sentiment Score for Heron Therapeutics Inc click here.

More About Heron Therapeutics Inc

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. Click Here to get the full Stock Report for Heron Therapeutics Inc stock.